Union minister of health and family welfare Mansukh Mandaviya took to Twitter on Tuesday to announce the government’s approval of BharatBiotech's Covaxin manufacturing facility in Gujarat’s Ankleshwar.“Govt of India approves vaccine manufacturing facility for production of BharatBiotech's Covaxin in Ankleshwar, Gujarat,” the minister tweeted. Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat. Bharat Biotech had said in a press statement that IIL’s Ankleshwar-based production facility will add another 200 million doses to its overall vaccine production. The Ankleshwar based manufacturing facility is expected to roll out vaccine doses from the fourth quarter of the year, PTI had reported on May 20. In the next two months we will be starting production in two of our facilities in Ankleshwar, Gujarat, and Bengaluru, Karnataka.

Source: Hindustan Times August 10, 2021 07:41 UTC